Home › Funds › EVERETT HARRIS & CO /CA/ › LH
EVERETT HARRIS & CO /CA/ position in LH
LABCORP HOLDINGS INC · Health Care
EVERETT HARRIS & CO /CA/ reported holding 129,602 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$39.9M, representing 0.52% of its reported portfolio and ranking #28 among its reported holdings. EVERETT HARRIS & CO /CA/ has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EVERETT HARRIS & CO /CA/'s LH position evolved
EVERETT HARRIS & CO /CA/ first disclosed a stake in LH in Q3 2023 at 13,513 shares (US$2.7M). The position peaked in Q3 2026 at 129,602 shares, worth US$39.9M. Across 13 filings, EVERETT HARRIS & CO /CA/ increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 129,602 shares valued at US$39.9M — an increase of 4,913 shares quarter over quarter.. Notable position changes include a 38% increase in Q4 2023 (shares fell 4% over the following quarter), a 47% increase in Q1 2026 (shares rose 5% over the following quarter), a 123% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 13.51K | $2.72M | New |
| Q4 2023 | 18.70K | $4.25M | Add |
| Q1 2024 | 23.58K | $5.15M | Add |
| Q2 2024 | 29.25K | $5.95M | Add |
| Q3 2024 | 30.51K | $6.82M | Add |
| Q4 2024 | 32.35K | $7.42M | Add |
| Q1 2025 | 32.54K | $7.57M | Add |
| Q2 2025 | 34.79K | $9.13M | Add |
| Q3 2025 | 34.28K | $9.84M | Reduce |
| Q4 2025 | 38.00K | $9.53M | Add |
| Q1 2026 | 55.94K | $14.93M | Add |
| Q2 2026 | 124.69K | $34.91M | Add |
| Q3 2026 | 129.60K | $39.93M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LH and 13F data
LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LH
- VICTORY CAPITAL MANAGEMENT INC 3.92M sh · $1.21B · Q3 2026
- Boston Partners 2.95M sh · $908.74M · Q3 2026
- Allspring Global Investments Holdings, LLC 2.08M sh · $632.21M · Q3 2026
- Select Equity Group, L.P. 1.98M sh · $554.95M · Q2 2026
- THRIVENT FINANCIAL FOR LUTHERANS 705.96K sh · $217.51M · Q3 2026
- Navera Investment Management Ltd. 647.87K sh · $199.60M · Q3 2026
More on EVERETT HARRIS & CO /CA/
FAQ
How long has EVERETT HARRIS & CO /CA/ held LH?
EVERETT HARRIS & CO /CA/ has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EVERETT HARRIS & CO /CA/'s current position in LH?
As of Q3 2026, EVERETT HARRIS & CO /CA/ holds 129.60K shares of LH (LABCORP HOLDINGS INC), valued at $39.93M, representing 0.52% of its reported portfolio and ranking #28.
Has EVERETT HARRIS & CO /CA/ been buying or selling LH?
In the latest 13F filing (Q3 2026), EVERETT HARRIS & CO /CA/ increased its position in LH. The position peaked in Q3 2026 at 129.60K shares.
Which other funds hold LH?
Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.